Clinical trials
Bipolar Disorder I or II clinical trials
Below are recruiting bipolar disorder i or ii clinical trials, each written for real people, not researchers. We’re tracking 2,361 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06967857RecruitingPhase 2
Dexamfetamine for adults with ADHD and depression
This trial tests a study medication (dexamfetamine) for adults who have both ADHD and moderate to severe depression. It aims to see if the medication is safe and helps improve both conditions.
FrankfurtAges 18–65 - NCT06969937RecruitingPhase 2
Ketamine and Neurofeedback for Alcohol Use Disorder
This study tests whether combining ketamine with a brain-training technique called neurofeedback can help people reduce or stop drinking alcohol. It may offer a new treatment option for alcohol use disorder.
ZurichAges 18–65 - NCT06971211RecruitingPhase 2
Radiation and drug combo for advanced prostate cancer
This trial combines radiation therapy with two drugs (fluzopanib and abiraterone acetate) to treat men with metastatic castration-resistant prostate cancer that hasn't been treated yet. The goal is to see if this triple approach helps slow the cancer's growth.
Shenyang, LiaoningAges 18 years+ - NCT06972368Recruiting
Home brain stimulation for depression in borderline personality disorder
This trial tests whether a gentle brain stimulation device (tDCS) used at home can help with depression in people with borderline personality disorder. If you have BPD and current depression, you may be able to participate from home using your smartphone.
Montreal, QuebecAges 18–65 - NCT06976697Recruiting
Home-based tDCS for major depression
This trial tests a home-use device that sends a small electrical current to the brain to treat major depression. It may be a good option if you are already on antidepressant medication and have a smartphone.
Boston, MassachusettsAges 22–70 - NCT06981195RecruitingPhase 2
Testing lemborexant for insomnia in people on buprenorphine
This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.
Richmond, VirginiaAges 18 years+ - NCT06986460RecruitingPhase 3
Low-frequency TMS for bipolar depression
This study tests whether low-frequency TMS (a gentle magnetic stimulation to a specific part of the brain) can help treat depression in people with bipolar disorder who did not get enough benefit from a previous study. You must be on a mood stabilizer and not taking certain anticonvulsant medications.
Toronto, OntarioAges 18 years+ - NCT06989125Recruiting
Online vs. video therapy for gambling disorder
This trial compares two types of cognitive behavioral therapy for gambling disorder: one you do online on your own schedule and one face-to-face with a therapist over video. The goal is to see which works better, so you can choose the option that fits your life.
Aarhus, DenmarkAges 18 years+ - NCT06989957RecruitingPhase 1
Psilocybin and MDMA therapy for PTSD in veterans
This study tests whether a combination of two investigational drugs, psilocybin and MDMA, can help veterans with post-traumatic stress disorder (PTSD). You would receive the drugs in a controlled setting and be monitored closely.
Baltimore, MarylandAges 21 years+ - NCT06994338RecruitingPhase 2
Tirzepatide for alcohol use disorder
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
Los Angeles, CaliforniaAges 21–65 - NCT07002034RecruitingPhase 2
RE104 for adjustment disorder related to cancer or other serious illnesses
This trial is testing a new medication (RE104) for people who have adjustment disorder with depressed mood or anxiety because of a serious medical condition like cancer, ALS, MS, Parkinson's, or lung fibrosis. It's a study to see if the drug is safe and reduces symptoms.
Birmingham, AlabamaAges 18–80 - NCT07002541Recruiting
Nerve block comparison for breast surgery pain
This study tests two different nerve-block methods (PECS-II and ESP) to see which better reduces painkiller use during breast surgery. A special monitor guides how much pain medicine you need. The goal is to help you recover with less opioid side effects.
IstanbulAges 18–80 - NCT07011147Recruiting
Real-world test of automated insulin delivery in primary care
This study tests if an automated insulin delivery system (the iLet bionic pancreas) works well in real-world primary care settings for people with type 1 or type 2 diabetes. It aims to see if this technology can help manage blood sugar more easily.
Aurora, ColoradoAges 18–89 - NCT07016399RecruitingPhase 2
Darolutamide before surgery for AR-positive triple-negative breast cancer
This trial tests a drug called darolutamide, alone or with standard chemotherapy, before surgery for a type of breast cancer that is triple-negative but has a high level of the androgen receptor (AR). It is for people with stage II or IIIA breast cancer that can be removed surgically.
Nashville, TennesseeAges 18 years+ - NCT07018791RecruitingPhase 3
Art-based pain test for jaw joint disorder patients
This trial tests if using art can help measure pain in people with temporomandibular joint disorders (TMD). It may offer a new way to understand and manage your pain without surgery.
Jeddah, Mecca RegionAges 18 years+ - NCT07020364Recruiting
Study of a single tool for prostate surgery using laser or bipolar energy
This study is testing a new way to perform prostate surgery using a single tool that can use either laser or bipolar energy. It aims to see if this approach is safe and effective for men with a large prostate (40 cc or more) who need surgery to help with urination problems.
Shibīn al Kawm, MenoufiaAges 50 years+ - NCT07021508Recruiting
Testing a new brain stimulation for bipolar depression
This trial tests a new type of brain stimulation called temporal interference stimulation to see if it can safely and effectively improve symptoms of bipolar depression. It may be an option for people who are not taking medication or who are willing to stop their current medication for a short time.
Hangzhou, ZhejiangAges 18–45 - NCT07025408RecruitingPhase 2
Testing a new burn treatment for second-degree burns
This trial tests a new medicine called KJ101 for healing deep second-degree burns. It may help close the wound faster and reduce scarring.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT07029529RecruitingPhase 2
Apremilast for alcohol use disorder
This study tests whether a drug called apremilast can help people who drink heavily reduce their alcohol use. You will take the medication daily for several weeks and attend study visits to track your progress.
New Haven, ConnecticutAges 21–65 - NCT07038798Recruiting
Deep rTMS for mild memory problems in older adults
This trial is testing whether a non-invasive brain stimulation technique called deep rTMS can help older adults with mild memory or thinking problems. It aims to see if this treatment can improve cognitive function without major side effects.
Hamilton, OntarioAges 60–90 - NCT07038811Recruiting
App for treating urgent or mixed urinary incontinence
This trial tests a smartphone app called Tät®II to help women with urgency or mixed urinary incontinence. The app may provide exercises and strategies to reduce symptoms without medication or surgery.
ÖstersundAges 18 years+ - NCT07042581RecruitingPhase 4
Revaree Plus for vaginal dryness in breast cancer survivors
This trial tests a vaginal insert called Revaree Plus to see if it helps breast cancer survivors who have vaginal dryness or pain from hormone therapy. It may be a good option if you are on an aromatase inhibitor or tamoxifen and have discomfort.
Basking Ridge, New JerseyAges 18 years+ - NCT07053098Recruiting
Boosting Alcohol Use Disorder Meds in Psychiatric Care
This study aims to help doctors and staff at three psychiatric clinics better prescribe medications for alcohol use disorder to patients with serious mental illness. It looks at whether extra support and guidance can improve treatment.
Baltimore, MarylandAges 18–90 - NCT07059013Recruiting
Chatbot program to support caregivers of children with autism
This trial tests a chatbot program designed to improve well-being for caregivers of children with autism spectrum disorder (ASD). It may help you feel more supported and manage the unique challenges of caring for a school-aged child with ASD.
Hong KongAges 18 years+
Hear when a new Bipolar Disorder I or II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bipolar disorder i or ii?
- Yes. Clin2 currently lists 2,361 recruiting bipolar disorder i or ii studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bipolar disorder i or ii trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bipolar disorder i or ii trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.